Home › Chronic Kidney Disease › Indiana
Pag-aaral pangklinika para sa Chronic Kidney Disease sa Indiana
7 pag-aaral para sa Chronic Kidney Disease ang naghahanap ng mga kalahok sa mga site sa Indiana.
Mga Lungsod sa Indiana
Opisyal na teksto ng pag-aaral (English)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Franciscan Physician Network - Indiana Heart Physicians, Indianapolis
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07783802A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, Indianapolis
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06742723A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
- Indiana University, Indianapolis
Nagre-recruitPhase 3
Edad 2 hanggang 17 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07107945Effects of Replacing High Protein Foods in People With Chronic Kidney Disease
- Purdue University, West Lafayette
Nagre-recruit
Edad 40 hanggang 70 · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT07105670Study of BHV-1400 in IgA Nephropathy
- Site-012, Indianapolis
Nagre-recruitPhase 1
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT07054684Ferric Citrate and Chronic Kidney Disease in Children
- Indiana U, Indianapolis
Nagre-recruitPhase 2
Edad 6 hanggang 18 · Lahat ng kasarian · Na-update Abr 17, 2026 · NCT04741646SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
- Lutheran Medical Group, Fort Wayne
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 17, 2026 · NCT06001827Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.